Testing magnesium doses for fast heart rate in atrial fibrillation
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether giving a higher dose of magnesium (4 grams) compared to a lower dose (2 grams) or a placebo can help control a fast heart rate during atrial fibrillation. It may help patients who are already receiving diltiazem.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have atrial fibrillation with a fast heart rate (at least 120 beats per minute).
- You are taking diltiazem to control your heart rate.
- You speak English.
- You do not have serious conditions like very low blood pressure, kidney failure, or a recent heart attack.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding magnesium to the standard heart-rate medicine metoprolol helps control a fast heartbeat better in people with atrial fibrillation. It may help slow the heart rate more quickly and reduce symptoms.
This trial tests two medicines — one taken by mouth (bisoprolol) and one given through an IV (diltiazem) — to see which is better at safely slowing a too-fast heartbeat in people with atrial fibrillation or flutter. If you have this heart rhythm problem with a fast rate and are otherwise stable, the study might help find the most effective way to bring your heart under control.
This trial tests a medication called etripamil to see if it can quickly slow down a rapid heart rate during episodes of atrial fibrillation. It may help people who have frequent, long-lasting episodes with a fast heartbeat.
This study tests a new type of heart scan (called magnetocardiography) to help doctors safely manage a heart rhythm medicine called dofetilide. The goal is to reduce the risk of an abnormal heart rhythm condition called long QT syndrome.
This study tests a stepwise treatment plan for people with persistent atrial fibrillation (a long-lasting irregular heartbeat) who also have an enlarged left atrium. It aims to see if a medication called amiodarone plus a cardioversion procedure can help restore normal rhythm.
This trial studies abnormal electrical signals in the right upper heart chamber and how they relate to atrial fibrillation (AF). It may help improve how doctors target AF treatment during catheter ablation for people who have AF symptoms.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.